Proclin 300

ProClin biocides are immediately microstatic upon contact with microbial organisms as a result of their ability to quickly penetrate cell membranes and inhibit specific enzymes crucial to cellular respiration. Multiple specific sites of ProClin toxicity prevent microorganisms from developing high…

Components: ProClin 150 5ml; ProClin 200 5ml; ProClin 300 5ml; ProClin 950 5ml RIDADR: UN 3316 9 NOTE: This product is available for use in biological diagnostic assays and IVDs only.  End users will be required to fill out an end-use declaration from MilliporeSigma.…

…Learn more. Application: Suggested starting dilutions are as follows: WB: 1:500-1:3000. Not yet tested in other applications. Optimal working dilutions should be determined experimentally by the end user. Physical form: 1XPBS, 20% Glycerol (pH7). 0.025% ProClin 300 was added as a preservative.

… Suggested starting dilutions are as follows: ICC/IF: 1:100-1:1000, WB: 1:500-1:3000. Not yet tested in other applications. Optimal working dilutions should be determined experimentally by the end user. Physical form: 1XPBS, 20% Glycerol (pH7). 0.025% ProClin 300 was added as a preservative.

…dilutions are as follows: IHC-P: 1:100-1:1000, WB: 1:500-1:3000, IHC-Wm: 1:100-1:500. Not yet tested in other applications. Optimal working dilutions should be determined experimentally by the end user. Physical form: 1XPBS, 20% Glycerol (pH7). 0.025% ProClin 300 was added as a preservative.

…Optimal working dilutions should be determined experimentally by the end user. Immunogen: Synthetic peptide corresponding to a region within amino acids 781 and 874 of LGR5 according to NP_003658 Physical form: 1XPBS, 1% BSA, 20% Glycerol (pH7). 0.025% ProClin 300 was added as a preservative.

…should be determined experimentally by the end user. Immunogen: Recombinant protein containing a sequence corresponding to a region within amino acids 2402 and 2513 of mtor according to NP_001070679 Physical form: 1XPBS, 20% Glycerol (pH7). 0.025% ProClin 300 was added as a preservative.

…dilutions should be determined experimentally by the end user. Immunogen: Recombinant protein containing a sequence corresponding to a region within amino acids 204 and 410 of tuba1 according to NP_919369 Physical form: 1XPBS, 20% Glycerol (pH7). 0.025% ProClin 300 was added as a preservative.

…should be determined experimentally by the end user. Immunogen: Recombinant protein containing a sequence corresponding to a region within amino acids 7 and 321 of gapdh according to NP_001108586 Physical form: 1XPBS, 20% Glycerol (pH7). 0.025% ProClin 300 was added as a preservative.

…should be determined experimentally by the end user. Immunogen: Recombinant protein fragment contain a sequence corresponding to a region within amino acids 391 and 661 of NAT10 according to AAH35558 Physical form: 1XPBS, 20% Glycerol (pH7). 0.025% ProClin 300 was added as a preservative.

…Optimal working dilutions should be determined experimentally by the end user. Immunogen: Recombinant fragment corresponding to a region within amino acids 45 and 268 of EFHA1 according to AAH31089 Physical form: 1XPBS, 20% Glycerol (pH7). 0.025% ProClin 300 was added as a preservative.

…dilutions should be determined experimentally by the end user. Immunogen: Recombinant protein containing a sequence corresponding to a region within amino acids 72 and 258 of phb according to NP_958454 Physical form: 1XPBS, 20% Glycerol (pH7). 0.025% ProClin 300 was added as a preservative.

…dilutions should be determined experimentally by the end user. Immunogen: Recombinant protein containing a sequence corresponding to a region within amino acids 445 and 664 of nat10 according to NP_956938 Physical form: 1XPBS, 20% Glycerol (pH7). 0.025% ProClin 300 was added as a preservative.

…should be determined experimentally by the end user. Immunogen: Synthetic peptide containing a sequence corresponding to a region within amino acids 364 and 377 of adipor1b according to NP_998665 Physical form: 1XPBS, 20% Glycerol (pH7). 0.025% ProClin 300 was added as a preservative.

…protein. Plays a role in the activation of T-cells. Immunogen: Recombinant protein containing a sequence corresponding to a region within amino acids 104 and 354 of lcp1 according to NP_571395 Physical form: 1XPBS, 20% Glycerol (pH7). 0.025% ProClin 300 was added as a preservative.

…an isozyme of ROCK1 is a target for the small GTPase Rho. [provided by RefSeq] Immunogen: Synthetic phospho-peptide corresponding to amino acids residues surrounding the phospho Ser1366 of ROCK2 Physical form: 1XPBS, 1% BSA, 20% Glycerol (pH7). 0.025% ProClin 300 was added as a preservative.

…5-prime monophosphate (Fujishige et al., 2000 [PubMed 10998054]).[supplied by OMIM] Immunogen: Recombinant fragment corresponding to a region within amino acids 547 and 779 of PDE10A according to AAI04859 Physical form: 1XPBS, 20% Glycerol (pH7). 0.025% ProClin 300 was added as a preservative.

…experimentally by the end user. Immunogen: Recombinant protein fragment contain a sequence corresponding to a region within amino acids 354 and 568 of NS3 (Dengue virus 2) according to NP_739587 Physical form: 1XPBS, 20% Glycerol (pH7). 0.025% ProClin 300 was added as a preservative.

…Mediates cell survival during the DNA damage process through activation of CDK2. Immunogen: Recombinant fragment corresponding to a region within amino acids 1 and 313 of SPDYA according to NP_877433 Physical form: 1XPBS, 20% Glycerol (pH7). 0.025% ProClin 300 was added as a preservative.

…experimentally by the end user. Immunogen: Recombinant protein fragment contain a sequence corresponding to a region within amino acids 117 and 301 of NS1 (Dengue virus 2) according to NP_739584 Physical form: 1XPBS, 20% Glycerol (pH7). 0.025% ProClin 300 was added as a preservative.

…activator. May function as a switch in neuronal development. Immunogen: Recombinant protein containing a sequence corresponding to a region within amino acids 42 and 238 of sox2 according to NP_998283 Physical form: 1XPBS, 20% Glycerol (pH7). 0.025% ProClin 300 was added as a preservative.

…possibly via induction of genes associated with apoptosis.[supplied by OMIM] Immunogen: Recombinant fragment corresponding to a region within amino acids 241 and 504 of ZC3H12A according to NP_079355 Physical form: 1XPBS, 20% Glycerol (pH7). 0.025% ProClin 300 was added as a preservative.

…experimentally by the end user. Immunogen: Synthetic peptide containing a sequence corresponding to a region within amino acids 2 and 13 of Capsid Protein (Dengue virus 2 ) according to NP_739591 Physical form: 1XPBS, 1% BSA, 20% Glycerol (pH7). 0.025% ProClin 300 was added as a preservative.

…Required for the looping stage of heart development. Immunogen: Recombinant protein containing a sequence corresponding to a region within amino acids 50 and 212 of tbx5a according to NP_570990 Physical form: 1XPBS, 1% BSA, 20% Glycerol (pH7). 0.025% ProClin 300 was added as a preservative.

…implicated in cervical cancers. [provided by RefSeq] Immunogen: Recombinant protein fragment contain a sequence corresponding to a region within amino acids 3 and 170 (P42336) of PI3 kinase p110 alpha Physical form: 1XPBS, 20% Glycerol (pH7). 0.025% ProClin 300 was added as a preservative.

…and conformation-independent manner. Potential oncogene. Immunogen: Synthetic peptide containing a sequence corresponding to a region within amino acids 448 and 490 (Q9H211) of CDT1 according to AAH08676 Physical form: 1XPBS, 20% Glycerol (pH7). 0.025% ProClin 300 was added as a preservative.

…response element, it is thought to be a transcription factor. [provided by RefSeq] Immunogen: Recombinant fragment corresponding to a region within amino acids 69 and 346 of KLF5 (Uniprot ID#Q13887) Physical form: 1XPBS, 20% Glycerol (pH7). 0.025% ProClin 300 was added as a preservative.

…been described, but their full-length nature is not known. [provided by RefSeq] Immunogen: Recombinant fragment corresponding to a region within amino acids 181 and 423 of TRPM2 according to NP_003298 Physical form: 1XPBS, 20% Glycerol (pH7). 0.025% ProClin 300 was added as a preservative.

…processibility during elongation of the leading strand. Immunogen: Recombinant protein containing a sequence corresponding to a region within amino acids 31 and 222 of pcna according to NP_571479 Physical form: 1XPBS, 1% BSA, 20% Glycerol (pH7). 0.025% ProClin 300 was added as a preservative.

…- an enzyme involved in lipoprotein metabolism. [provided by RefSeq] Immunogen: Recombinant fragment corresponding to a region within amino acids 1 and 189 of Apolipoprotein D according to NP_001638 Physical form: 1XPBS, 20% Glycerol (pH7). 0.025% ProClin 300 was added as a preservative.

…by the end user. Immunogen: Recombinant protein fragment contain a sequence corresponding to a region within amino acids 1 and 495 of Envelope protein (Dengue virus 2) according to NP_739583 Physical form: 1XPBS, 20% Glycerol (pH7). 0.025% ProClin 300 was added as a preservative.

…erythrokeratoderma, both inherited skin diseases. [provided by RefSeq] Immunogen: Synthetic peptide corresponding to a region within amino acids 1 and 46 of Loricrin according to NP_000418 Physical form: 1XPBS, 1% BSA, 20% Glycerol (pH7). 0.025% ProClin 300 was added as a preservative.